Telerad Group Introduces AI-Based Solution for Pulmonary Embolism Detection
Written by Arushi Sharma
Telerad Group's unveiling of PE Assist at RSNA 2023 marks a monumental leap in medical technology. This AI-driven solution redefines Pulmonary Embolism (PE) detection, empowering radiologists worldwide with precise chest CT angiogram analysis.
Telerad Group has introduced an innovative AI-driven solution aimed at supporting radiologists worldwide, enhancing the precision and efficiency of Pulmonary Embolism (PE) detection. PE, a critical medical condition affecting millions globally, occurs when a blood clot obstructs the arteries in the lungs, posing severe, life-threatening risks.
The breakthrough technology, named Pulmonary Embolism Assist (PE Assist), was unveiled at the Radiological Society of North America (RSNA) event held from November 26-29, 2023. This revolutionary tool promises to redefine global medical diagnostics, particularly in the analysis of chest and thoraco-abdominal Computed Tomography angiography.
PE Assist is meticulously crafted to aid radiologists by highlighting and communicating suspected positive findings of chest CT angiograms, expediting interventions and potentially saving lives. Leveraging cutting-edge artificial intelligence algorithms, PE Assist analyzes medical images, categorizes thrombus into four subclasses, and delivers crucial information regarding the presence or absence of right heart strain.
Dr. Arjun Kalyanpur, CEO and Chief Radiologist at Teleradiology Solutions, expressed, “PE Assist signifies more than just a technological leap; it represents a paradigm shift showcasing the immense potential of Indian innovation on the global stage. This groundbreaking solution has the capacity to transform pulmonary embolism diagnostics, offering healthcare professionals a tool that swiftly identifies potential cases and facilitates rapid intervention, ultimately saving lives.”
The introduction of PE Assist marks a significant stride in medical technology, exemplifying the impactful synergy between cutting-edge AI and diagnostic radiology, poised to revolutionize the approach towards detecting and addressing pulmonary embolism on a global scale.